S SARS-CoV-2 Spike Glycoprotein mRNA
4.8 (751) · $ 17.99 · In stock
SARS-CoV-2 spike protein and messenger ribonucleic acid found to translocate into the nucleus
Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS- CoV-2 spike glycoprotein
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Streamline your COVID-19 studies with constructs expressing a humanized SARS-CoV-2 Spike Glycoprotein (S) - based on SBI's robust lentivector
SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector
Frontiers SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
SARS-CoV-2 Proteins
Research Solutions for Coronavirus – SBI - Stratech
Viruses, Free Full-Text
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
Life Cycle
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [CR3022] (ab273073)
Vaccine-induced COVID-19 mimicry syndrome
